In patients with pancreatic cancer, Treg cells are an important component involved in the inhibition of tumor immune response by disordering the functions of CD4+ T and CD8+ T cells, macrophages, NK cells and DC cells (105, 106). The gene discussed is CD8A; the disease is familial pancreatic carcinoma.